Melanoma (Skin) Stage IV Completed Phase 1 Trials for Nivolumab (DB09035)

Also known as: Stage 4 Melanoma / Melanoma Stage Iv / Stage IV Skin Melanoma / Stage IV Melanoma

IndicationStatusPhase
DBCOND0109891 (Melanoma (Skin) Stage IV)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02716948SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or SpineTreatment